1. Home
  2. RECT vs IRD Comparison

RECT vs IRD Comparison

Compare RECT & IRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RECT
  • IRD
  • Stock Information
  • Founded
  • RECT 1997
  • IRD 2018
  • Country
  • RECT Singapore
  • IRD United States
  • Employees
  • RECT N/A
  • IRD N/A
  • Industry
  • RECT
  • IRD
  • Sector
  • RECT
  • IRD
  • Exchange
  • RECT Nasdaq
  • IRD NYSE
  • Market Cap
  • RECT 66.1M
  • IRD 59.1M
  • IPO Year
  • RECT 2024
  • IRD N/A
  • Fundamental
  • Price
  • RECT $4.80
  • IRD $1.13
  • Analyst Decision
  • RECT
  • IRD Strong Buy
  • Analyst Count
  • RECT 0
  • IRD 3
  • Target Price
  • RECT N/A
  • IRD $6.33
  • AVG Volume (30 Days)
  • RECT 1.5K
  • IRD 247.2K
  • Earning Date
  • RECT 08-07-2025
  • IRD 08-15-2025
  • Dividend Yield
  • RECT N/A
  • IRD N/A
  • EPS Growth
  • RECT N/A
  • IRD N/A
  • EPS
  • RECT 0.14
  • IRD N/A
  • Revenue
  • RECT $33,502,767.00
  • IRD $13,651,000.00
  • Revenue This Year
  • RECT N/A
  • IRD $51.41
  • Revenue Next Year
  • RECT N/A
  • IRD $68.84
  • P/E Ratio
  • RECT $35.02
  • IRD N/A
  • Revenue Growth
  • RECT 8.42
  • IRD N/A
  • 52 Week Low
  • RECT $2.70
  • IRD $0.65
  • 52 Week High
  • RECT $7.68
  • IRD $2.09
  • Technical
  • Relative Strength Index (RSI)
  • RECT N/A
  • IRD N/A
  • Support Level
  • RECT N/A
  • IRD N/A
  • Resistance Level
  • RECT N/A
  • IRD N/A
  • Average True Range (ATR)
  • RECT 0.00
  • IRD 0.00
  • MACD
  • RECT 0.00
  • IRD 0.00
  • Stochastic Oscillator
  • RECT 0.00
  • IRD 0.00

About RECT Rectitude Holdings Ltd Ordinary Shares

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks.

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

Share on Social Networks: